Hera Biotech, Inc.
StreetZero Signal 71
About Hera Biotech, Inc.
Hera Biotech, Inc. is a biotechnology company founded in 2020 and headquartered in San Antonio, Texas, with additional operations in Monterrey, Mexico. It develops non-invasive, tissue-based diagnostic tests focused on endometriosis and cervical cancer to advance standards in women's health diagnostics. The company operates with 11-50 employees and maintains a website at herabiotech.com highlighting its MetriDx platform and AI-powered tools.
LATEST FUNDINGPrivate Placement
$1.7M
Announced 2026-09-23
TOTAL RAISED$3.21M
IN THE NEWS
- 🔗 Hera Biotech - 2026 Company Profile, Team & Competitors - Tracxn
- 🔗 Hera Biotech - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 Hera Biotech - 2026 Funding Rounds & List of Investors - Tracxn
- 🔗 Hera Biotech - Advancing the Standard of Care in Women's Health Diagnostics
- 🔗 Hera Biotech - Diagnosing Endometriosis and Cervical Cancer
EMPLOYEES11-50
FOUNDED2020
HQSan Antonio, Texas, US
Industry
Biotechnology
Tags
BiotechnologyDiagnosticsWomen's HealthEndometriosis
Investors
Key highlights
- Developer of non-invasive diagnostic test kits for endometriosis and cervical cancer.
- Raised $3.21M total across five seed rounds with eight institutional investors.
- Headquartered in San Antonio, TX with 11-50 employees and focus on AI-powered women's health tools.
- Specialties include reproductive health diagnostics and advancing care for underdiagnosed conditions.
Ask StreetZero about Hera Biotech, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account